🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsDanuglipron BID dosing — looking for input Page 2

Danuglipron BID dosing — looking for input

paige_pharma Sun, Apr 6, 2025 at 1:07 AM 9 replies 1,464 viewsPage 2 of 2
jason_paloalto
Member
212
890
Nov 2024
Palo Alto, CA
Apr 6, 2025 at 2:40 AM#6

The figures, for anyone assembling their own picture. Keep the original post as written when you update it, and add the correction underneath. An edited-away mistake is invisible to the next person who makes it.

14 9tane_welly, Dr.PathRoch, mona_PHX and 11 others
Reply Quote Save Share Report
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Apr 6, 2025 at 3:16 AM#7

Following on from Dr.ObesityLA — and this may be the naive question:

How much of the oral variability is the SNAC absorption window and how much is dose, because the two get conflated constantly?

Last edited: Apr 6, 2025 at 4:16 AM
13 8MikeFit_NJ, InsuranceTom, WendyG_ATL and 10 others
Reply Quote Save Share Report
NurseLeah_Nash
Member
278
1,234
Sep 2024
Nashville, TN
Apr 6, 2025 at 3:52 AM#8
jason_paloalto said:
Keep the original post as written when you update it, and add the correction underneath.

Adding the part of the answer the thread has not reached. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.

12 7PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 9 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
paige_pharma
Member
289
1,234
Sep 2024
Omaha, NE
Apr 6, 2025 at 4:28 AM#9

Closing the loop on my own question.

I moved the tablet to the moment I wake up rather than trying to fit it around breakfast, and the difference in the following weeks was obvious. It was a timing problem, not a dose problem.

11 6lisa_labSD, adam_van, Dr.SurgeonPGH and 8 others
Reply Quote Save Share Report
Dr.PainCLE
Senior Member
1,234
6,234
Mar 2024
Cleveland, OH
Apr 6, 2025 at 7:21 AM#10
NurseLeah_Nash said:
It is worth asking what the claim would look like if it were false.

Agreeing with NurseLeah_Nash, and the qualification matters more than the agreement. The absorption variability is real, but it partly averages out over weeks — the steady-state trough is less erratic than any single day would suggest. Where it bites is in the first fortnight, when people conclude the tablet does nothing.

37 10amy_econ_NJ, bbq_ray_KC, oliver_london and 34 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register